The activity of.T lymphocyte precursors (pre-T cells) in the bone marrow of mice was measured by the concanavalin A response synergy assay. Pre-T cell levels were low in marrow of neonatally thymectomized mice and could be restored to control values by treatment in vivo with an extract of mouse thymus. Levels of activity were also low in aging mice and again could be restored by thymic extract treatment. The most profound fall with ang was in the proliferating pre-T cell compartment as detected bytritiated thymidine suicide; and this compartment was restored by thymic extract treatment. Irradiation to the thymus, with the bone marrow shielded, caused a fall in resting pre-T cells in the bone marrow and a concomitant rise in proliferating cells. These results are consistent with a model of control of pre-T cell maturation in which the thymus senses the number of developing iymphocytes within it and responds to a fall in this number by increasing production of hormone. The hormone acts on resting pre-T cells in the marrow, stimulating some of them to proliferate, leave the bone marrow, and repopulate the thymus.
it and responds to a fall in this number by increasing production of hormone. The hormone acts on resting pre-T cells in the marrow, stimulating some of them to proliferate, leave the bone marrow, and repopulate the thymus. Thymus-dependent lymphocytes (T cells) of adult mammals undergo maturation in three successive locations. First, the precursors of T cells (pre-T cells) develop in the bone marrow from pluripotential stem cells. These precursors can be demonstrated by their ability to reconstitute an irradiated recipient's thymus (1) , by the induced expression of surface markers such as Thy-I and TL (2) , and by their synergistic interaction with mature T cells in the response to mitogens (3) . When pre-T cells reach some as-yet-undefined stage of development, they leave the bone marrow, and some find their way to the thymus, where the second, intrathymic stage of maturation takes place. It is probable that information about "self" is acquired at this stage (4) . Finally, cells are exported from the thymus to peripheral lymphoid tissues, where further maturation of the T1 to T2, or Lyt 1+, 2, 3+ to Lyt 1+ and Lyt 2, 3+ types may occur.
It is generally assumed that the maturation of lymphocytes, at stages prior to antigen contact, is under some kind of homeostatic control. A considerable body of work has implicated a humoral factor, or hormone, made by the thymus, in the maturation of T cells. Unfortunately, there is no consensus regarding the nature or effects of this postulated hormone, and it has been difficult to demonstrate consistent or complete maturation of pre-T cells to T cells under its influence (for reviews, see refs. 5 and 6). We have recently been examining pre-T cells in mouse bone marrow, and have found that the number or activity of such cells is low in thymus-deficient mice. Furthermore, they can be restored to control levels by in vivo administration of an extract of mouse thymus. These findings have led us to postulate that the thymus, by its hormonal activity, regulates pre-T cell proliferation via a negative feedback loop.
MATERIALS AND METHODS
Mice. Male CBA/J mice, 7 weeks old, were obtained from The Jackson Laboratory, Bar Harbor, ME. Hybrid CAF1 (BALB/c X A/J) and LAF1 (C57L X A/He) mice were bred in our animal quarters, using Jackson parental stocks. Hybrid mice were anesthetized and thymectomized by suction within 24 hr of birth. In sham-thymectomized controls the thymus was exposed but not removed. All mice were assiduously examined at the end of the experiment for residual thymus tissue; none was found in any of the thymectomized mice.
Lymphocyte Preparations. Bone marrow was flushed from femurs and tibias with Hanks' balanced salt solution and passed through a 25-gauge needle. Axillary, brachial, and inguinal lymph nodes were removed and pressed through a 100-mesh screen to obtain a single-cell suspension. Cortisol-resistant thymocytes (CRT) were obtained in a similar manner from the thymuses of mice injected intraperitoneally 36 were harvested with a Brandel automated harvester and the DNA, precipitated with 5% trichloroacetic acid, was measured by liquid scintillation counting. Cultures were done in triplicate.
The Con A response of bone marrow was calculated by subtracting the mean thymidine incorporation (cpm) of the control cultures (no Con A) from the mean cpm with Con A (experimental minus control, E -C). A similar procedure was carried out on the CRT or lymph node data, and on those of the mixtures. Finally, "synergistic cpm" was computed by the formula: synergistic cpm = (E -Cmixture)
-(E-Cmarrow + E -CCRT or lymph node). This value, which represents the extra cpm in a mixture when pre-T cells enhance the response of mature T cells to Con A, is a linear function of bone marrow cell number. Different bone marrow preparations can be compared if the slopes of doseresponse curves are parallel, which they were in this study.
Local Irradiation of the Thymus. In experiments involving local thymic irradiation, CBA/J mice were anesthetized with secobarbital, taped to a board, and covered with a 7-mm-thick lead shield in which a 12 X 6 mm port had been cut; this port was positioned carefully over the thymus. A dose of 220 roentgens (1 roentgen = 2.58 X 10-4 coulombs per kilogram) was delivered to the thymus by a GE Maxitron 250 x-ray unit, at 250 kV peak, 30 mA, with 0.5 mm Cu and 1 mm Al filtration (half-value layer,'1.36 mm Cu). The dose rate was 113 roentgens/min. Sham-irradiated mice were only given secobarbital and immobilized.
Cell Cycle Characteristics of Bone Marrow Pre-T Cells. To determine if the pre-T cells responsible for synergy were in active cell cycle (proliferating) or not, we subjected samples of bone marrow to tritiated thymidine suicide. This was accomplished by exposing 5 X 106 cells in 1 ml of pre-warmed tissue culture medium to 10 AtCi of tritiated thymidine, specific activity 90 Ci/mmol (New England Nuclear) for 1 hr at 37"C. Cells were then washed twice and made back to starting volume. Control samples of cells were treated similarly, except for addition of tritiated thymidine. In suicide experiments, [125I]iododeoxyuridine (Schwarz/Mann) instead of tritiated thymidine was used to pulse cultures at 42-48 hr. The synergistic activity that was lost after tritiated thymidine suicide was considered to be due to pre-T cells in S phase of the cell cycle; activity that remained was probably associated with cells in Go or prolonged G1. Thus the percent of activity that is sensitive to suicide is a measure of the fraction of cells in cycle. This technique and interpretation are commonly used in investigations of hematopoietic stem cell kinetics (7) .
Thymic Extract. An extract was prepared from 3-g batches of CBA/J thymus by the method used for calf thymosin fraction 3 (8) . The extract contained no endotoxin detectable by the Limulus amebocyte lysate test (9) . It was prepared in sterile saline and administered to mice intraperitoneally. Identical extracts were prepared from mouse spleen and kidney to be used as controls, but this had to be abandoned when it was found that the spleen extracts were toxic, and the kidney extracts lethal, to normal mice. Consequently, control mice received only saline; better controls will have to await isolation of the hormonally active principle.
RESULTS

Pre-T Cells in Marrow of Neonatally Thymectomized
Mice. Neonatal CAF1 and LAFI mice were thymectomized or sham-operated. When the CAF1 mice were 5 weeks old, and the LAF1 mice 5 months old, they were given daily injections of 50,ug of thymic extract, Monday to Friday, for 3 weeks. They were killed 3 days after the last injection, and the synergistic capacity of their bone marrow was tested with CRT from untreated young syngeneic donors. Control groups consisted of thymectomized mice given saline and sham-operated mice given' thymic extract or saline. We found (Fig. 1 ) that synergistic ability, and therefore pre-T cells, is low in the bone marrow of thymectomized animals (50% compared to shams). Pre-T cell activity was restored to control levels or greater by treatment with the 'thymic extract. Such treatment of shamthymectomized mice had no effect upon their bone marrow synergy.
Pre-T Cells in Marrow from Aging Mice. The previous preliminary experiment showed that levels of pre-T activity are low in marrow of neonatally thymectomized mice and indicated that this might be due to a lack of thymic humoral factors. We therefore decided to examine the marrow of older mice, because it has been reported (10) that serum levels of a thymic humoral factor fall markedly with age. The synergistic ability of marrow from CBA/J mice of 12, 32, and 56 weeks of age was determined. In this experiment, the fraction of synergizing cells in S phase was also measured. It can be seen (Fig   2) that the total synergistic activity falls with age. Furthermore, the thymidine suicide experiments show that most or all of the fall is in the S phase or rapidly cycling compartment. Fig. 2 . Thymus extract treatment produced a 290% increase in cycling (sensitive to thymidine suicide) activity, different from the activity of saline-treated controls at P = 0.01. (0) to thymidine suicide. Both these activities differed from activity in control animals (P = 0.05) at 1, 2, and 5 weeks.
for synergistic activity, compared to that of sham-irradiated controls. Again, S phase and resting activity were distinguished by thymidine suicide. We found (Fig. 4 ) that thymic irradiation was followed by a clear rise in the proportion of pre-T cells in S phase in the bone marrow; this was 134% of control at 1 week and fell to below control at 5 weeks. There was, pari passu, a fall in resting synergistic activity, to 34% of control at 2 weeks; the activity recovered to above control levels at 5 weeks. Total synergistic activity did not differ significantly from that of control marrow at any time (data not shown). Thymic lymphoid cell counts were 27%, 72%, and 86% of control at 1, 2, and 5 weeks, respectively, indicating that the thymus had been adequately irradiated and was recovering.
DISCUSSION
This study concerns the control of activity or numbers of pre-T cells in the bone marrow. Pre-T cells were estimated by an indirect technique based on the synergy of pre-T cells with mature T cells in the response to Con A (3). The nature of this synergy is at present unknown, although it may be an example of the virtually universal requirement of T cells for interaction with other cells in order to become activated. Whatever the explanation for the phenomenon, it has been especially helpful to us because it can be used to estimate both resting and cycling pre-T cells.
We first observed that pre-T cell activity is low in the bone marrow of thymus-deprived or thymus-deficient animals, namely, neonatally thymectomized mice or aged mice. It is also low in the marrow of nude mice (3) and after adult thymectomy (unpublished data). When neonatally thymectomized mice were treated with a crude extract of mouse thymus (comparable to calf thymosin fraction 3), the level of pre-T cell activity in the bone marrow was restored to that seen in shamoperated controls. This was restoration, not a nonspecific stimulatory effect on bone marrow cells, because sham-operated animals treated with the same extract were not affected. Thus, a deficiency in the bone marrow of thymus-deprived mice could be corrected by a thymic humoral factor.
The next series of experiments showed that the decline in pre-T cell activity seen with aging is primarily due to a fall in . j
Immunology: Cohen and Fairchild cycling cells, that is, cells whose activity is abolished by radioactive thymidine suicide. Thymidine suicide kills cells that are in cycle at the time the marrow is removed, and thus reflects the in vivo situation. This decline in cycling cells with age is interesting, because it parallels the reported fall in serum thymic-dependent humoral factors in the aging mouse (10) and human (8, 10) . The connection between pre-T levels and thyrnic factors was made explicit by treating old mice with the thymic extract (Fig. 3) ; the levels of pre-T activity were restored to those observed in young mice. Furthermore, most of the restoration was due to an increase in cycling pre-T cells.
It seems reasonable to conclude from these data that the thymus controls the level of pre-T cells in the bone marrow by means of a humoral factor, whose major role is to stimulate resting pre-T cells (in Go or prolonged G1 phase) into proliferation. This is remarkably similar in concept to the control of another hematopoietic system-erythropoiesis-by its humoral factor, erythropoietin. In erythropoiesis a distant sensor (in the kidney) measures blood oxygen content, and responds to low PO2 by increasing the production of erythropoietin. This hormone acts at the bone marrow level, stimulating proliferation and concomitant maturation of erythroid precursors. On the assumption that Nature is conservative and repeats effective strategies, we postulate that the thymus contains a sensor for the number of thymocytes within it, and, when the number falls, it increases the production of its hematopoietic hormone. This, like erythropoietin, acts at the bone marrow level, increasing proliferation and maturation of its target cell, in this case the T cell precursor.
This hypothesis was tested by giving mice irradiation localized to the thymus, which destroyed at least 75% of the lymphoid cells. At 1 and 2 weeks after irradiation, there were significant increases in the proportion of cycling pre-T cell activity and falls in the resting compartment. We interpret these results to mean that, as a response to the loss of thymocytes after irradiation, the thymus increased its output of hormone, which triggered resting pre-T cells into proliferation. By 5 weeks there was recovery, and indeed overshoot, a common phenomenon in negative feedback systems seen, for example, in the recovery of thymus cell numbers after cortisol treatment (13) .
On the basis of -these experiments we feel justified in constructing a model (Fig. 5 ) of the control of T cell precursor development. This model, it should be stressed, is a minimal one, which gives what appears to be the simplest explanation of the observations made so far. We believe the major role of the thymic hormone is to cause proliferation of pre-T cells in the bone marrow, both to increase their number and, probably, their maturation so that they can be exported and repopulate the thymus. Under normal conditions this would be a finely tuned negative feedback control system serving to maintain the number of developing intrathymic lymphocytes constant. As the model stands, it indicates no role for the thymic hormone in maturation of the T cell lineage beyond the bone marrow stage. This may explain the failure of many workers, including ourselves, to observe consistent effects of various thymnic factors on maturation of thymic or postthymic cells (see refs. 5 and 6). The model, however, does not rule out intrathymic effects for the factor we have been studying, and there could be other thymic humoral factors with later actions. Because the extract we used is from mouse thymus, we do not know whether the activity we observed is due to any of the described peptides in calf thymosin fraction 5 (8) or to principles related to thymopoietin (14) , facteur thymique serique (10), thymic humoral factor (15) , or any other thymus-derived substance. It should be informative to compare other preparations, including some from other species, for their activity in our pre-T cell stimulation system. A hematopoietic hormone should have three activities: It should maintain its target cell and cause it to differentiate and proliferate (12) . We have shown previously that the thymus extract maintains pre-T cells in vitro (3), and differentiation, at least to the extent of displaying new surface markers, is easily demonstrated (2, 16) . We show here that the third criterion is met in ivo, and thus that the thymus produces a hematopoietic hormone strictly analogous to colony-stimulating factors and erythropoietin. On the basis of this knowledge, it should now be possible to develop an in vitro colony technique for pre-T cells.
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